Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy

Background: A substantial number of patients with esophageal squamous cell carcinoma (ESCC) do not achieve complete remission after definitive concurrent chemoradiotherapy (dCRT). We performed this retrospective study to evaluate the efficacy and safety of apatinib combined with S-1/capecitabine as...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Dongmei, Chen, Baoqing, Guo, Suping, Bai, Kunhao, Ma, Huali, Hu, Yonghong, Li, Qiaoqiao, Zhu, Yujia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034932/
https://www.ncbi.nlm.nih.gov/pubmed/33713398
http://dx.doi.org/10.18632/aging.202652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034932/
https://www.ncbi.nlm.nih.gov/pubmed/33713398
http://dx.doi.org/10.18632/aging.202652

Ejemplares similares